As of 1:31 PM on the 25th, Peptron is trading at 23,900 KRW, down 5.91% from the previous day. This represents a 45.73% increase compared to May 29. Peptron is known as a bio company specializing in peptide pharmaceuticals.
Over the past five days, individual investors have net purchased 191,853 shares, while foreigners and institutions have net purchased 85,088 shares and net sold 147,855 shares, respectively.
On June 24, Peptron became a market issue with a sharp rise due to news of a patent related to targeted anticancer drugs.
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
